Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 773-785

  van Kasteren, Puck B ^a   Beugeling, Corrine ^a   Ninaber, Dennis K ^a   Frias Staheli, Natalia ^b,c   van Boheemen, Sander ^a,d   García Sastre, Adolfo ^b   Snijder, Eric J ^a   Kikkert, Marjolein ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ENZYME; MDA5 PROTEIN; NONSTRUCTURAL PROTEIN 2; OVARIAN TUMOR DOMAIN CONTAINING DEUBIQUITINASE; PAPAIN LIKE PROTEASE 2; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RIG I LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON PRODUCTION; MOUSE; NAIRO VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UBIQUITINATION;

ANIMALS; ARTERIVIRUS; ARTERIVIRUS INFECTIONS; CELL LINE; DEAD-BOX RNA HELICASES; ENDOPEPTIDASES; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IMMUNITY, INNATE; MICE; MICE, TRANSGENIC; NAIROVIRUS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; UBIQUITIN; VIRAL PROTEINS;

ARTERIVIRUS; NAIROVIRUS;

EID: 84856844697     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06277-11     Document Type: Article

References (76)

1. Akutsu M, Ye Y, Virdee S, Chin JW, Komander D. 2011. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. U. S. A. 108:2228-2233.
2. Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171-176.
3. Barretto N, et al. 2005. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 79: 15189-15198.
4. Bergeron E, Albarino CG, Khristova ML, Nichol ST. 2010. Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J. Virol. 84:216-226.
5. Bhoj VG, Chen ZJ. 2009. Ubiquitylation in innate and adaptive immunity. Nature 458:430-437.
6. Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of pattern-recognition receptor signaling. Nat. Rev. Immunol. 8:911-922.
7. Capodagli GC, et al. 2011. Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J. Virol. 85:3621-3630.
8. Clementz MA, et al. 2010. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 84:4619-4629.
9. Devaraj SG, et al. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282:32208-32221.
10. de Vries AA, Chirnside ED, Horzinek MC, Rottier PJ. 1992. Structural proteins of equine arteritis virus. J. Virol. 66:6294-6303.
11. Enesa K, et al. 2008. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283:7036-7045.
12. Faaberg KS. 2008. Arterivirus structural proteins and assembly. In Perlman S, Gallagher T, Snijder EJ (ed), Nidoviruses. ASM Press, Washington, DC.
13. Fitzgerald KA, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
14. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-616.
15. Frias-Staheli N, et al. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2:404-416.
16. Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. 2009. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitinlike domain and catalytic domain regulate antagonism of IRF3 and NF-κB signaling. J. Virol. 83:6689-6705.
17. Gack MU, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
18. Gale P, et al. 2010. The feasibility of developing a risk assessment for the impact of climate change on the emergence of Crimean-Congo haemorrhagic fever in livestock in Europe: a review. J. Appl. Microbiol. 108: 1859-1870.
19. Graham FL, van der Eb AJ. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
20. Habjan M, et al. 2008. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032.
21. Hadari T, Warms JV, Rose IA, Hershko A. 1992. A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J. Biol. Chem. 267:719-727.
22. Han J, Rutherford MS, Faaberg KS. 2009. The porcine reproductive and respiratory syndrome virus nsp2 cysteine protease domain possesses both trans- and cis-cleavage activities. J. Virol. 83:9449-9463.
23. Hato SV, et al. 2007. The mengovirus leader protein blocks interferonalpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell. Microbiol. 9:2921-2930.
24. Higgs R, et al. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitinmediated degradation of IRF3. J. Immunol. 181:1780-1786.
25. Inn K-S, et al. 2011. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85:10899-10904.
26. James TW, et al. 2011. Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domaincontaining protease. Proc. Natl. Acad. Sci. U. S. A. 108:2222-2227.
27. Kanneganti TD. 2010. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10:688-698.
28. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663.
29. Kato H, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28.
30. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
31. Kayagaki N, et al. 2007. DUBA: a deubiquitinase that regulates type I interferon production. Science 318:1628-1632.
32. Lee MH, et al. 2011. RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus (HTNV) replication. J. Gen. Virol. 92(Pt 9): 2191-2200.
33. Li H, et al. 2010. The cysteine protease domain of porcine reproductive and respiratory syndrome virus non-structural protein 2 antagonizes interferon regulatory factor 3 activation. J. Gen. Virol. 91:2947-2958.
34. Li J, Liu Y, Zhang X. 2010. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J. Virol. 84:6472-6482.
35. Li S, et al. 2010. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 285:4291-4297.
36. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
37. Lindner HA, et al. 2005. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 79:15199-15208.
38. Luo R, et al. 2008. Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses interferon-beta production by interfering with the RIG-I signaling pathway. Mol. Immunol. 45:2839-2846.
39. Makarova KS, Aravind L, Koonin EV. 2000. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 25:50-52.
40. Nasirudeen AM, et al. 2011. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl. Trop. Dis. 5:e926.
41. Neumann EJ, et al. 2005. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 227:385-392.
42. Nijman SM, et al. 2005. A genomic and functional inventory of deubiquitinating enzymes. Cell 123:773-786.
43. O'Neill LA, Bowie AG. 2010. Sensing and signaling in antiviral innate immunity. Curr. Biol. 20:R328-R333.
44. Papon L, et al. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393: 311-318.
45. Parvatiyar K, Barber GN, Harhaj EW. 2010. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J. Biol. Chem. 285: 14999-15009.
46. Pasternak AO, Spaan WJ, Snijder EJ. 2006. Nidovirus transcription: how to make sense? J. Gen. Virol. 87:1403-1421.
47. Paz S, et al. 2009. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29: 3401-3412.
48. Pedersen KW, van der Meer Y, Roos N, Snijder EJ. 1999. Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J. Virol. 73:2016-2026.
49. Rodriguez-Madoz JR, et al. 2010. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J. Virol. 84:9760-9774.
50. Sabbah A, et al. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073-1080.
51. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
52. Saitoh T, et al. 2006. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7:598-605.
53. Sang Y, Ross CR, Rowland RR, Blecha F. 2008. Toll-like receptor 3 activation decreases porcine arterivirus infection. Viral Immunol. 21: 303-313.
54. Sawicki SG, Sawicki DL, Siddell SG. 2007. A contemporary view of coronavirus transcription. J. Virol. 81:20-29.
55. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
56. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
57. Shembade N, Ma A, Harhaj EW. 2010. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327:1135-1139.
58. Shi HX, et al. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30: 2424-2436.
59. Skaug B, Chen ZJ. 2010. Emerging role of ISG15 in antiviral immunity. Cell 143:187-190.
60. Snijder EJ, Wassenaar AL, Spaan WJ, Gorbalenya AE. 1995. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J. Biol. Chem. 270:16671-16676.
61. Snijder EJ, Meulenberg JJ. 1998. The molecular biology of arteriviruses. J. Gen. Virol. 79(Pt 5):961-979.
62. Sun Q, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642.
63. Sun SC. 2008. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8:501-511.
64. Sun Z, Chen Z, Lawson SR, Fang Y. 2010. The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J. Virol. 84:7832-7846.
65. Tseng PH, et al. 2010. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11:70-75.
66. van Aken D, Zevenhoven-Dobbe J, Gorbalenya AE, Snijder EJ. 2006. Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main proteinase is essential for equine arteritis virus replication and includes internal cleavage of nsp7. J. Gen. Virol. 87:3473-3482.
67. van der Meer Y, van Tol H, Locker JK, Snijder EJ. 1998. ORF1a-encoded replicase subunits are involved in the membrane association of the arterivirus replication complex. J. Virol. 72:6689-6698.
68. Wang D, et al. 2011. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85:3758-3766.
69. Ward CL, Omura S, Kopito RR. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-127.
70. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res. 64:145-160.
71. Wojdyla JA, et al. 2010. Papain-like protease 1 from transmissible gastroenteritis virus: crystal structure and enzymatic activity toward viral and cellular substrates. J. Virol. 84:10063-10073.
72. Yu Y, Hayward GS. 2010. The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33:863-877.
73. Zhang M, et al. 2008. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res. 18: 1096-1104.
74. Zheng D, Chen G, Guo B, Cheng G, Tang H. 2008. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 18:1105-1113.
75. Zhou L, Yang H. 2010. Porcine reproductive and respiratory syndrome in China. Virus Res. 154:31-37.
76. Ziebuhr J, Snijder EJ, Gorbalenya AE. 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81:853-879.